Skip to main content

Beginning a Discussion of the Supreme Court's Term

Image result for briefcase of cash

Another term of the U.S. Supreme Court has come and gone and, once again as in years past, I’d like to say something about it in this blog. Since it’s my blog, I hereby award myself that wish, over the course of this and the next three posts.

I don’t plan to discuss Jevic Holding. That was a very important decision, re-affirming ideas foundational to bankruptcy law, but … I’ve already taken a couple of cracks at it in this blog, and would have nothing new to say now.

I was tempted, in my earliest outlining of this discussion, by the idea of discussing at some length recent events in the public finance and politics of Puerto Rico. These events (including a very strikingly pro-statehood referendum result) in large part follow from the Supreme Court’s decisions on Puerto Rican matters last term. But I’ll save myself some time and give the matter the ‘elevator’ treatment: subsequent events have been entirely consistent with my treatment of those decisions at the time. 

Coming Attractions

So: what will I discuss? I’ll spend most of the rest of this post on the Court’s big insider-trading case of this term, Salman.  Tomorrow I’ll turn to other non-constitutional cases (that is, cases turning on the interpretation of statutes). In particular, tomorrow’s portfolio includes Bank of America v. Miami (on predatory lending and cities as plaintiffs), Honeycutt (on the Comprehensive Forfeiture Act) , and Sandoz v. Amgen, (on the marketing of "biosimilars" under the Biologics Price Competition and Innovation Act.)

On Saturday we’ll discuss some of the big constitutional issues of this term. There’s a trademarks-as-free-speech decision, one on the application of the equal protection clause to racial gerrymandering; one on regulatory takings and … perhaps you’ve heard something about a ‘travel ban’? .

Finally, on Sunday, we’ll discuss sex. This term saw its share of sex-and-the-constitution cases: involving continued resistance to gay marriage, a Facebook post by a convicted sex offender, and even boringly old procreative sex where it intersects with immigration/citizenship policy.

Insider Trading

Without further ado….

On December 6, 2016, the Court issued a decision in Salman v. United States, upholding what is known as a “friends and family” insider-trading/securities-fraud conviction.

Defense counsel had argued that Salman should not have been convicted because he had not given the source of his tips anything in consideration for same.

A Citigroup investment banker with a big mouth blabbed to his brother about an impending acquisition. The brother in turn blabbed to Bassam Salman. Neither link in this short chain seems to have involved cash-in-a-briefcase reciprocity one generally sees when an insider trade is featured in a Hollywood movie.

But the court in a 1983 case, Dirks, had said that although some element of exchange is required, cash in the briefcase is not.  The benefit to the tipper from the tippee need not be direct or financial. The court in Dirks suggested that amongst family members there is a general you-wash-my-hands expectation that allows a jury to infer personal benefit to the tipper from the family context of the tip itself. “My brother is always bugging my for some good dirt – I had to tell him something so he’d shut up on the subject – I was compensated by silence from that quarter for a little while” – that sort of thing is benefit enough.  And juries can presume that sort of thing.

The precedential value of  Dirks suffered an apparent blow in 2014, when the 2d Circuit, in United States v. Newman,  emphasized that prosecutors may not “prove the receipt of a personal benefit by the mere fact of a friendship, particularly of a casual or social nature.”

Even with a friends-and-family tip-off, there should be evidence that represents “at least a potential gain of a pecuniary or similarly valuable nature.” In the case before it in Newman the 2d Circuit found that the evidence “was simply too thin to warrant the inference” that the finder of fact would have to draw.  For this and other reasons, the convictions of the defendants in THAT case were reversed. That was especially important because the 2d Circuit is the Circuit that includes Wall Street – it is the one Circuit most important for such matters, and most likely t to be followed by the others. It is not the Supreme Court, though.

So has the great victory the defense bar thought they had won in 2014 has become "dust in the wind" of 2017? Well, not really. As Gregory Morvillo explained on a “corporate compliance & enforcement” blog sponsored by New York University, some of the reasoning involved in Newman survives Salman.

Indeed, a footnote to the SCOTUS opinion says, “The Second Circuit also reversed the Newman defendants’ convictions because the Government introduced no evidence that the defendants knew the information they traded on came from insiders or that the insiders received a personal benefit in exchange for the tips.” When information goes from an insider to a family member to a third party, the ignorance of that third party is a defense. That remains the case. The issues of knowledge of the personal benefit and the nature of the personal benefit required are in principle distinct.

That said: as readers probably know, I personally believe the criminalization of insider trading is a mistake, and I regard every new exception and limitation to that criminalization as a good thing. So this decision is unfortunate.

Good News

 Here’s a brief piece of good news, before I end this day’s blogging. The famous “who’s on first?” comedy routine associated with the immortal names of Abbott and Costello is apparently now in the public domain.

The 2d Circuit said so last year, and the Supreme Court this year denied cert.
So mess around with the punny names of imaginary baseball players all you wish, dear readers, without fear of liability. I’ll be back tomorrow to discuss other weighty Supreme Court stuff.


  1. Do you need free YouTube Views?
    Did you know that you can get these ON AUTOPILOT AND ABSOLUTELY FOR FREE by registering on Like 4 Like?


Post a Comment

Popular posts from this blog

A Story About Coleridge

This is a quote from a memoir by Dorothy Wordsworth, reflecting on a trip she took with two famous poets, her brother, William Wordsworth, and their similarly gifted companion, Samuel Taylor Coleridge.

We sat upon a bench, placed for the sake of one of these views, whence we looked down upon the waterfall, and over the open country ... A lady and gentleman, more expeditious tourists than ourselves, came to the spot; they left us at the seat, and we found them again at another station above the Falls. Coleridge, who is always good-natured enough to enter into conversation with anybody whom he meets in his way, began to talk with the gentleman, who observed that it was a majestic waterfall. Coleridge was delighted with the accuracy of the epithet, particularly as he had been settling in his own mind the precise meaning of the words grand, majestic, sublime, etc., and had discussed the subject with William at some length the day before. “Yes, sir,” says Coleridge, “it is a majestic wate…

Cancer Breakthrough

Hopeful news in recent days about an old and dear desideratum: a cure for cancer. Or at least for a cancer, and a nasty one at that.

The news comes about because investors in GlaxoSmithKline are greedy for profits, and has already inspired a bit of deregulation to boot. 

The FDA has paved the road for a speedy review of a new BCMA drug for multiple myeloma, essentially cancer of the bone marrow. This means that the US govt has removed some of the hurdles that would otherwise (by decision of the same govt) face a company trying to proceed with these trials expeditiously. 

This has been done because the Phase I clinical trial results have been very promising. The report I've seen indicates that details of these results will be shared with the world on Dec. 11 at the annual meeting of the American Society of Hematology. 

The European Medicines Agency has also given priority treatment to the drug in question. 

GSK's website identifies the drug at issue as "GSK2857916," althou…

Hume's Cutlery

David Hume is renowned for two pieces of cutlery, the guillotine and the fork.

Hume's guillotine is the sharp cut he makes between "is" statements and "ought" statements, to make the point that the former never ground the latter.

His "fork" is the division between what later came to be called "analytic" and "synthetic" statements, with the ominous observation that any books containing statements that cannot be assigned to one or the other prong should be burnt.

Actually, I should acknowledge that there is some dispute as to how well or poorly the dichotomy Hume outlines really maps onto the analytic/synthetic dichotomy. Some writers maintain that Hume meant something quite different and has been hijacked. Personally, I've never seen the alleged difference however hard they've worked to point it out to me.

The guillotine makes for a more dramatic graphic than a mere fork, hence the bit of clip art above.

I'm curious whe…